
Ozette Technologies
Ozette: An AI-enabled life sciences startup specializing in immune monitoring.

Ozette: An AI-enabled life sciences startup specializing in immune monitoring.
Ozette Technologies was founded with the core mission to revolutionize life sciences through advanced data analytics. The company specializes in developing an AI-enabled immune monitoring platform that aims to unlock the secrets of the immune system. By leveraging artificial intelligence, Ozette provides detailed mapping and analysis of the immune system, facilitating accelerated research and personalized healthcare solutions. Their market focus includes pharmaceutical companies, research institutions, and healthcare providers seeking to deepen their understanding of immune responses.
Notable affiliated individuals include experts in immunology and data science, although specific names are not provided. The company has attracted significant interest from investors in the biotech and AI sectors. Key achievements include the development of a robust platform capable of detailed immune system analysis, which has already shown promise in accelerating research outcomes. Overall, Ozette Technologies is making a substantial impact by providing tools that enhance the precision and efficiency of immune system research.
Companies similar to Ozette Technologies include Immunai, Omix.ai, CellChorus and ImmuneID.
Ozette Technologies was founded in 2021.
Ozette Technologies' headquarters is located in Seattle, WA, US.
Ozette Technologies' most recent funding round was for $26M (USD) in July 2022.
As of Jul 28, 2022, Ozette Technologies has disclosed funding of $32M (USD). Undisclosed round amounts are excluded.
Ozette Technologies has 48 employees as of Feb 5, 2024.
ImmuneID